Showing results (301-310 of 365) with videos related to

Sort By:
Pageof 37
The Journal of Pathology|September 27, 2024
DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymomaMehdi Latiri, Mohamed Belhocine, Charlotte Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Stephan Stilgenbauer, et al.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2020
Genome-Wide DNA Methylation Profiling in Early Stage I Lung Adenocarcinoma Reveals Predictive Aberrant Methylation in the Promoter Region of the Long Noncoding RNA PLUT: An Exploratory StudySoo-Zin Kim-Wanner, Yassen Assenov, Mridul B Nair, et al.
International Journal of Cancer|March 3, 2016
LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patientsAndreas Mock, Christoph Geisenberger, Christian Orlik, et al.
Oncoimmunology|March 28, 2017
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancerDyah L Dewi, Soumya R Mohapatra, Saioa Blanco Cabañes, et al.
Scientific Reports|June 29, 2016
Prenatal maternal stress and wheeze in children: novel insights into epigenetic regulationSaskia Trump, Matthias Bieg, Zuguang Gu, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Pageof 37